Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1994-06-16
1996-10-08
Fleisher, Mindy
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 71, C12Q 168, G01N 3353
Patent
active
055630359
ABSTRACT:
ERF-1 is shown to be a transcriptional regulator of the expression of the estrogen receptor, where elevated ERF-1 is related to elevated expression of the estrogen receptor. By monitoring the level of ERF-1, one can relate phenotypic characteristics of carcinomas expressing ERF-1 as prognostic of the response of the tumor to various therapies. In addition, ERF-1 may be used for screening therapeutic drugs which may act as antagonists to initiation of estrogen receptor transcription.
REFERENCES:
Weigel et al, Cancer Research (1993); vol. 53: pp. 3472-3474.
Hakim, "Prognostic Significance of mRNA-Encoding Estrogen Receptor and Epithelial Growth Factor Receptor in Breast Carcinoma Progression into Lymph Nodes: 1. Estrogen Receptor Encoding mRNA," J. Surg. Oncology (1989) 40:21-31.
Fleisher Mindy
McKelvey Terry A.
Rowland Bertram I.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Estrogen receptor regulation and its uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen receptor regulation and its uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen receptor regulation and its uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-56177